INTRODUCTION
There are two faces of aging. One face, which reflects the common perception of aging, associates it with an increase in morbidity and mort ality and a progressive decline in independence and autonomy. The other face, much less acknowledged despite growing evidence, associa tes aging with improved ment al health including life satisfaction, happiness, and wisdom. It is import ant to consider both aspects to develop plans for promoting wellness and healthy aging among people with ment al disorders including substance use disorders. This article summarizes the current informa tion base, identifies gaps in knowledge, and presents recommendations for a research agenda in this arena.
Common disorders of aging include hypertension heart disease, cancer, diabetes, Alzheimer disease an rela ted dementias, and geriatric syndromes such as f al and incontinence. Four-fifths of adults o ver age 65 hav at least one chronic disease and 77% have at least two Moreo ver, these st atistics do not reflect the high burde of mental illnesses and behavioral problems amon persons with dementia. The prevalence of depressiv disorders in older adults is expected to more tha double by 2050, 2 and of major concern, substance us disorders-including alcohol use disorder-are als on the rise among older adults. 3 Data show that eve as average lifespan among the baby boomers ha increased over the past several decades, the averag "heal thspan ," which is the number of years morbidity free, has not.
At the same time, however, many studies have shown that well-being and sa tisfaction with life improve in la ter life. What has been called the paradox of aging posits that as a person gets older physical health declines and ment al health tends to impro ve. 4 Older adul ts who are physically, cognitively, and socially active have been found to have higher levels of emotional regulation, compassion, empathy, self-reflection, and experience-based social decision-making-the characteristics that constitute wisdom-than younger adults. 5 Studies have suggested neurophysiologic reasons for these improvements: recruitment of additional neuronal networks in performing an activity to compensate for age-associated loss of synapses and neurons and neuroplasticity as new syn apses and new neurons in specific brain regions are formed. Even among people with mental disorders such as schizophrenia, subjective well-being and psychosocial functioning often increase with age. Jeste et al. 6 have promoted a positive psychiatry of aging that focuses on promotion of health and well-being and prevention of mental disorders through enhancement of positive psychosocial f a ctors relevant to ment al or physical illnesses. En ablers of impro ved heal th and longevity include resilience, optimism, and social engagement, with medium to large effect sizes in published empirical studies.
To achieve these benefits, there is a need for a shift away from hospital-and clinic-based treatments to interventions and support in the home and community. Involvement of community-based primary care and mental health sites, the aging network, mobile interventions, and a wider use of technology could f a cilitate the delivery of more efficient person-centered care to a broader segment of the population, including those in rural communities. Around the world there is a call for the establishment of age-friendly and dementiafriendly communities that would provide accessible housing, transportation, outdoor spaces, social engagement, and community support, along with educational, occupational, and leadership opportunities and health and wellness services and care.
With the aging of persons born between 1946 and 1964, the population of older adults in the United States will double fr om 2010 to 2030, putting addition al strain on available mental health resources. Recognizing the need to build consensus around wha t needs to be done Stein Institute for Research on Aging at the Univers ty of California San Diego convened top academic provider, and public policy experts in the field of ger ia tric ment al health, patient advocacy organiza tions, an representatives from appropriate federal agencies t explore the essential mental and behavioral health con cerns of older Americans, identify gaps, and propos solutions. The round table agenda and a list of pan elists can be found in Appendix 1, along with a list o meeting attendees. Here, we present a summary o these discussions and recommendations for movin forward.
Because numerous topics were covered during th roundtable and time was limited , a few topics were con sidered to be "out of scope" for the days discussion First, although more resources are always desirable we did not discuss increased funding as a potentia solution. However, it was okay to discuss how to re allocate resources and what priorities for fundin should be in the future. Second, although workforc shortages and other challenges are immense, we di not have enough time to tackle them at the round table. Finally, because we were honored to be joine at the roundtable by a number of representatives from the federal government, we did not discuss nationa politics or related matters.
DEMENTIA
Dementia is a major neurocognitive disorder, an at present there are no evidence-based intervention to prevent or significantly impact cognitive impairment At the same time, neuropsychiatric symptoms (NPS such as depression, agitation, apathy, psychosis, an sleep disorders are among the most common and dis tressing symptoms for people with dementia and the family caregivers. Although evidence-based psycho social interventions have shown promise in managin these symptoms, unfortun ately they are rarely used i everyday clinical practice. Among people with A zheimer disease, depression is the earliest observabl symptom in at least one-third of cases. 8 Additionall milder symptoms of agitation may manifest early an increase in prevalence and severity with worsening o dementia, often leading to an increase in famil caregiver burden, greater morbidity, poorer quality o and hearing loss, are often under-diagnosed and undertrea ted in older adults and may contribute to confusion, agitation, and anxiety, thus complicating and possibly exacerbating cognitive symptoms. 10 The use of mul tiple medica tions, including o ver-the-counter medications, which is common in older adults, may further adversely affect cognition.
Caring for older adults who present with a combin ation of medical, cognitive, and behavioral challenges requires substantial resources and presents difficulties with transitions of care as symptoms progress.
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Challenging behaviors absent appropria te supports may also make it more difficult for certain individuals to access supported housing or home and communitybased services and social supports. As a result, these individuals often end up living in institutional settings such as nursing homes.
Lack of stimulation and environmental cues in the nursing home environment may exacerbate cognitive and behavioral symptoms. Cognitive impairment also makes older people especially vulnerable to fraud, which may be perpetrated by family members or other close relatives and friends.
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Progress in Improving Dementia Care
In recent years federal agencies and private institutions have adopted policies to improve the care and treatment of older individuals with dementia. One of the most promising models is offered by the U.S. Department of Veterans Affairs, which pro vides integra ted care from primary care to subspecialties. The Department of Veterans Affairs has also implemented STAR-VA, patterned after Teri's STAR (Staff Training in Assisted living Residences) program. This program takes an interdisciplinary behavioral approach to manage challenging dementia-related behaviors. 13 Federal agencies are also working to reduce fraud through the Consumer Financial Protection Bureau's Office of Financial Protection for Older Americans and the Federal Trade Commission's "Pass It On" financial fraud campaign.
The Centers for Medicare & Medicaid Services (CMS) has embraced the concept of person-centered care and implemented novel ways to ensure that older adults receive appropria te services and supports. For example, in 2012 the CMS launched the National Partnership to agency also developed new reimbursement codes t improve diagnosis of dementia and coordination o care; the CMS has mandated a 30-day medicatio review to reduce overmedication and flag prescrip tions that may exacerbate NPS. More time is neede to evaluate the effectiveness of these new safeguard Moving forward, the CMS has also established severa internal "Affinity Groups" to address issues related t the care of older persons; these include groups tar geted at dementia, nursing homes, and home an community-based services. Additionally, local com munities such as Arlington, Virginia, offer a "Senio Adult Mental Health Program" that provides geria ric mental health services through interdisciplinar teams, including home-based services.
The Nation al Institutes of Health (NIH) has also in vested in research on programs designed to improv the care of people with dementia. In concert with th CMS, for example, in 2014 it funded the MIND (Max mizing INDependence) at Home program at John Hopkins University in Baltimore, Maryland.
14 Th developers of the program estimate that providin coordinated care at home, delivered by trained nonclinical community workers under the superv sion of a geriatrician, may delay or prevent nursin home admission and has the potential to offer bette care at low cost. To accelerate clinical research and allow for comparability of data acr oss studies and in the clin ical setting, the NIH has also developed the NIH Toolbox (www.NIHToolbo x.org), a set of well-valida te and normed measures of behavioral and neurologi function that are brief and have low subject burden Validation of these measures is currently underway fo people with mild cognitive impairment and early A zheimer disease. Similar work is needed for othe patient populations to be able to examine variabilit in risk architecture and response to preventive an treatment interventions.
Gaps
Further progress in developing programs to mana g NPS associa ted with dementia is stymied by a numbe of research, clinical, educational, and reimbursemen gaps. The underlying mechanisms of NPS are com plicated and poorly understood; hence, targete therapies are difficult to implement. 15 A combinatio reserve are believed to pla y important roles. However, in the research aren a insufficient longitudinal data have been collected on the emotional and behavioral aspects of dementia. There has also been insufficient study of comorbidities among persons with dementia and the impact those have on the development and management of NPS. 16 Similarly, there is a dearth of research on effectiveness of interventions including services and supports designed to improve the lives of people with dementia.
Clinicians and nursing home staff receive little formal education about caring for individuals with NPS and neurodegenerative disease. Likewise, there is poor understanding and recognition among clinicians, family caregivers, and the general public regarding mental health issues that individuals with dementia may have. 17 Clinicians may also not be aware that older individuals with dementia frequently become victims of fraud and abuse. Compounding this limited knowledge, some clinicians lack reliable tools to assess and manage the NPS in dementia patients. Some clinicians who perform community-based mental health and heal th outreach are well equipped to teach f amily caregivers and community volunteers how to work with people with NPS, but there is little support for these activities.
There are few programs that integrate physical and ment al heal thcare, and although there has been a trend toward reducing the use of antipsychotics, a lack of altern ative U.S. Food and Drug Administration-appr oved pharmacologic treatments and a dearth of evidencebased yet practical nonpharmacologic therapies often result in inappropriate or inadequate treatment. Additionally, when alternative, nonpharmacologic treatments are available, they often are not reimbursable by public or private payers. Moreover, payment incentives for home, outpatient, and institutional settings are often not aligned with best practices for assisting people with dementia and their family caregivers.
There is a lack of data-driven information on which to base decisions regarding improvements to dementia care, such as when to use or reduce antipsychotic use, the best potential treatments for agitation in dementia, and the benefits and dra wba cks associated with bifurcating treatment for psychosis and agitation. In addition, drug development for NPS is complicated 
Recommendations from Pubic Stakeholders
DEPRESSION AND SUICIDE
Depression is a serious illness across all age groups, yet it is frequently under-recognized and undertrea ted in older individuals. 19 Many medical, social, and environmental factors unique to older people increase their risk of depression. These factors include high rates of cerebrovascular disease and other neurologic and neurodegenerative diseases, cognitive impairment, surgery, and hospitalization; as well as social and environmental factors such as retirement, financial limitations, loneliness, bereavement (particularly complicated or prolonged grief), and isolation. The biologic aging process may also increase the risk of depression in ways that are not well understood. Many older people have multiple chronic conditions, such as cardiovascular disease, diabetes, and arthritis, that further increase their risk of depression. 20, 21 Depression, in turn, tends to complicate the treatment of these conditions, leading to poorer outcomes and increased mort ality rates. 22 The f a ct that many blood pressure medications are central nervous system depressants adds to the mix. 23 Older adults are also at a high risk of suicide, which is most often a consequence of the convergence of several risk factors, including depression, disability, social disconnection, and access to lethal means. 24 It is worth adding tha t suicide is not always linked to depression. Although the suicide rate of middle-aged Americans aged 45-54 has recently surpassed older age groups, people over 75 remain among the highest risk groups. 25 These numbers are expected to increase further as the popula tion ages, particularl y among baby boomers, who have historically high rates of suicide. 24 increase the risk of suicide among older adults. Thos who have previously attempted suicide are at a par ticularly high risk, as well as those with one or mor terminal illnesses.
Pharmacologic treatments are effective in at leas 60% of older adults with major depression 26 and fre quently cause side effects that can lead to significan problems, such as falls. A combination of psycho therapy such as cognitive behavior therapy an antidepressants has been shown to ameliorate depres sion in older adults. 27 Nonpharmacologic treatment such as problem-solving therapy, increased physica activity, meditative interventions, and general wel ness promotion , are also effective in many cases. 28 Ye the stigma of mental illness and suicide often pre vents people from seeking the care they need Marginalized subpopula tions may face additional ris factors and barriers to getting help. For example, olde gay men who experienced the HIV epidemic may ex perience survivor guil t and isolation as well as housin discrimination and access to only a small caregive network.
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Progress
Person alized therapy for depression represents a new frontier in managing depression. For example, brie nonpharmacologic therapies delivered in primary car settings have shown promise in treating depression and in preventing depression in older persons. 31 Programs designed to enhance community-base social connection and increase access to mental healt services for older adults, such as the STAR program mentioned earlier, 13 have also emerged. Specificall related to suicide prevention and Emergency Depar ment Safety Assessment and Follow-up Evaluation, STAR has demonstrated effectiveness in identifying in dividuals at risk of suicide before discharge. 13 Increase public awareness and education, as well as partner ships with nontraditional organizations outside th healthcare system, have demonstrated feasibility an impact, such as the educational collaboration betwee the American Foundation for Suicide Prevention an the National Shooting Sports Foundation, which i rolling out suicide prevention education, including ad dressing lethal means during periods of risk, withi the gun-owning community. 33, 34 the Research Domains Criteria program, which led to the creation of a research framework that would lead to a better understanding of brain mechanisms underlying depression, as well as risk and causal factors. 35 In addition, the current director of the National Institute of Mental Health, Dr. Gordon, has prioritized the development of suicide prevention pr ograms. In 2016, the 21st Century Cures Act for the first time authorized a grant program for adult suicide prevention efforts, and Congress provided funding for these grants in Fiscal Year 2017. The CMS also reports progress in creating payment codes that will enable reimbursement for services that may be helpful in behavioral health, such as codes for collaborative care, cognitive assessment, and advanced care planning. The CMS health risk assessment and annual wellness visit for Medicare beneficiaries includes screening for depression, questions on alcohol consumption, and detection of cognitive impairment (https://www.medicareinteractive.org/get-answers/ medicare-covered-services/preventive-care-services/ annual-wellness-visit). The American Foundation for Suicide Prevention (www.AFSP.org) is the nation's leading philanthropic agency supporting research into suicide prevention, epidemiology, and neurobiology. The American Foundation for Suicide Prevention funds research into suicide across the life cy cle and has played a major role in training generations of researchers in suicidology.
The Substance Abuse and Mental Health Services Administration (SAMHSA), an agency of the U.S. Department of Health and Human Services, in addition to the newly authorized grants for adult suicide prevention offers many free ma terials to clinicians and the public online (https://store.samhs a.gov). And in 2017, the U.S. Department of Health and Human Services released a draft strategic plan for 2018-2022 that included a number of behavioral heal th objectives rela ted to suicide and depression. At the time of the workshop, public comments were still being accepted regarding this plan.
Gaps
Many older adults lack access to behavioral healthcare services. In primary healthcare and communal living settings, efforts to address older adults' mental and staff about best practices. Evaluation of existin and emerging programs has also been inadequate Current federal privacy laws inhibit the ability of som providers to access medical records and treatmen history.
Despite increased attention from many stakehold ers regarding depression and suicide risk in olde adults, barriers and myths regarding suicide amon older adults remain. No rapidly acting drugs have ye been approved for suicidal idea tion , although ket amin is sometimes used off-label to treat depression. I treatment-resistant depression-pharmacotherapy a ug mentation strategies, including the use of atypica antipsychotic agents and lithium carbonate-may hav particular value in reducing the intensity of suicida ideation in depressed older adults. 36 Much less i known about preventing or treating suicidal ideatio in older adults who do not have a depressive disorde Learning-based psychotherapies, such as problem solving therapy, may usefully address cognitive ris factors for suicide in older depressed adults, especia ly those with executive dysfunction. Integration o community-based and clinical programs is impera tive to optimally address suicide risk among olde Americans. 37 Physicians and other healthcare workers may fail t identify older adults at high risk of suicide. 38 Studie are needed on the use of suicide prevention pro grams for older adults seen in emergency dep artment who present with depression or suicidal ideation.
Recommendations from Public Stakeholders
• Consider Healthcare System solutions tha enhance depression, other mental health, an suicide outcomes, such as the integration of be havioral health in primary care, or even simpl treating depression screening as part of routin health maintenance at primary care visits.
• Consider suicide preventive models such as th Zero Suicide framework, 39 which identifies peopl at risk for suicide, closes gaps in care, trains staf and impro ves access to evidence-based suicide ris reducing treatment modalities.
• Embrace a public health approach that teache basic scientific fa cts, risk f a ctors, and warning sign for depression and suicide risk to all layers o increased competency to provide social support, connection, referral, and follow-up to prevent suicide and impro ve the detection of mental heal th needs. 40 • 
SERIOUS MENTAL ILLNESSES AND SUBSTANCE USE DISORDERS
Older people with serious mental illnessesincluding schizophrenia, schizoaffective disorder, an bipolar disorder-are among the most disenfran chised population groups with regard to healthcare an thus have not benefitted from the general popula tion's gain in longevity. For example, individuals wit schizophrenia experience accelerated physical aging resulting in an average lifespan that is 15-20 year shorter than unaffected people. A recent study sug gests that the mortality gap for schizophrenia ha increased by 37% since the 1970s. 42 Smoking, seden t ary lifestyle, poor diet, and poor access to primary car combine to increase these individuals' risk of hear disease, diabetes, and other chronic diseases.
In December 2017 SAMHSA's Interdepartmenta Serious Mental Illness Coordinating Committee re leased its first report to Congress, which found tha individuals with serious mental illnesses are furthe burdened by social factors, including loss of indepen dence and autonomy, sometimes resulting in a findin
of incompetency (https://store.samhs a.gov/product/ PEP17-ISMICC-RTC). Indeed, predictors of sustained remission in schizophrenia include social support and being or having been married as well as early initiation of trea tment and grea ter cognitive and personality reserve. 43 Alcohol and other substance use disorders, including a rise in opioid use disorder, have also increased in prevalence among older adults for a variety of reasons 3 yet are also under-recognized and undertreated. As people age their sensitivity to alcohol increases, and the effects of alcohol may be magnified by the concomitant use of other drugs or the presence of other illnesses, including psychiatric illnesses. The use of cannabis for either medical or recreational purposes is particularly high among younger older adults. Prescription drugs, including benzodiazepines and opioids, are used frequently by older persons. When prescription and nonprescription drugs are used in combination with each other and/or alcohol, they can be p articularly danger ous. Unfortunately, opioid abuse and misuse, which was recently recognized by the federal government as a public health crisis, has not exempted older adults.
Progress
Nonpharmacologic interventions such as cognitive behavioral social skill training and other cognitiveand functional-enhancing therapies have demonstrated effectiveness in older persons with schizophrenia. 44 Another important trend in the care of people with serious mental illnesses is supported decision-making, which offers an alternative to substituted decision-making or guardianship. 43 Supported decision-making has been used most commonl y among people with developmental disabilities. It allows the person with the disability or mental illness to choose who will provide assistance with decision-making. That person may be a family member, clergy member, family caregiver, or friend; the important point is that the person gets to choose. The Department of Health and Human Services has funded a national resource center for alternatives to guardianship (http://www.supporteddecisionmaking.org/).
More research is clearly needed to identify effective management strategies for people with serious on Schizophrenia and Depression, is the nation's to private funder of mental illness research, providin grants totaling nearly $4 billion since 1987. The Brai & Behavior Research Foundation aims to augmen federal research support by providing seed fundin for young investigators as well as mid-career, inde pendent, and senior investigators who may be pursuin new ideas outside of the mainstream or who ar making a transition from another field of research.
Given the high prevalence of alcohol use disorde in the United States, the National Institute of Alcoho Abuse and Alcoholism, in collaboration with SAMHSA recently launched an online treatment navigato (https://alcoholtreatment.niaaa.nih.gov/) to guide in dividuals through a step-by-step process for findin professionally led treatment. The navigator educate users about alcohol use disorder and trea tment option for adults and provides instruction for finding qual fied treatment providers and helps older people an others find appropriate alcohol treatment options.
Gaps
There remain many unmet needs for older person with serious ment al illness including dementia and sub stance use disorders. These include inadequat treatment alternatives, a paucity of large populatio studies in diverse populations to document the exten of the problems, lack of healthcare providers traine in the care of older adults with mental disorders, an the lack of research relevant to the experienced live of older persons who have them, as well as the need of their f amily caregivers. 45 Such studies could provid essential informa tion about the effects of marijuan a an other substances in older populations and the impac of subst ance use interactions with other comorbid con ditions and with the numerous medica tions that olde adults typically are prescribed.
Adequate care for older persons with these disor ders will, however, require attention to curren shortcomings in terms of access to care. Although th health risk assessment tool associated with Med icare's Annual Wellness Visit may include question related to subst ance use, follow-up care for such prob lems in older people remains limited . For older person with serious mental illnesses, there remain substan tial gaps with regard to the process of enabling thes
Recommendations from Public Stakeholders
• Develop and test the effectiveness of broad, community-based interventions to identify and treat older persons with co-occurring serious mental illnesses and substance use disorders, including the Screening Brief Intervention and Referral to Treatment, which has been shown to be effective in older adults. 46 • Develop and test models to ensure implementation of evidence-based treatment plans for serious mental illnesses that begin with psychosocial or behavioral interventions (such as cognitive behavior social skills training) along with U.S. 
SUMMARY OF RECOMMENDATIONS AND NEXT STEPS TO IMPROVE OUTCOMES FOR OLDER POPULATIONS FROM PUBLIC STAKEHOLDERS
Below we summarize recommendations for variou conditions discussed above into a general list appl cable to older adults with mental disorders includin substance use disorders.
1. Provide person-centered care in home and com munity whenever possible and in most integra te settings whenever appropriate.
• Make home the center of care.
• • This should include staff in long-term care settings as well as clinicians, family members, 47 payers, and the general public.
• Engage the gun-owning community in suicide prevention efforts. 4. Identify and implement best practices for diagnosis and treatment.
• Enable early but accurate diagnosis of NPS in persons with dementia (e.g., agitation, apathy, psychosis, etc.) and understand their etiology to develop targeted personalized interventions, services, and supports.
• Identify and emphasize low-cost/high-impact interventions such as those that can be pro-
• Support research to develop risk calcula tors fo producing adverse outcomes including cha lenging behaviors such as wandering screaming, and severe a gitation , in people wit dementia.
• Support dissemination and implement ation re search to bridge science and service.
• Develop policies and efforts to encourage in clusion of minority and other underserve older popula tions and persons with substanc use disorders in clinical studies (similar to wha was done in pediatrics), with due concern fo the vulnerability of older people to advers effects with certain interventions.
• Improve infrastructure for conducting clin cal trials (e.g., registries, observational studie and clinical trial networks) and use of elec tronic medical record systems for conductin "virtual clinical trials." • Ensure that all programs are evaluated an found to be effective before implementation 5. Coordinate efforts of all stakeholders: patient family caregivers, governmental agencies healthcare providers, academic institutions pharmaceutical companies, medical technolog companies, and advocacy organizations.
• Convene all relevant agencies within U.S. De partment of Health and Human Services t address the current lack of coordination i implementing evidence-based interventio strategies and avoid silo effects, with a focu on integrated care. • There should be more emphasis on researc in these common problems faced by olde people. Encourage academic institution and professional organizations to embrac and work with other institutions and organ zations to address issues that might othe wise fall between the cracks (e.g., sleep an stress).
• Working with advocacy groups, involve en users, including patients and family caregiv ers as well as other relevant stakeholders, i priority setting and development of models t improve outcomes for older adults with ment a disorders.
